Nátrium-Hidrogénkarbonát B.Braun (Sodium Hydrogen Carbonate)

Sodium Hydrogen Carbonate, the active ingredient in Nátrium-Hidrogénkarbonát B.Braun, is an alkali agent presented as a powder for oral use. It is employed to correct metabolic acidosis, neutralize gastric acid, and alkalinize urine in adult and pediatric patients when clinically indicated.

GNH USA supplies Nátrium-Hidrogénkarbonát B.Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory support across multiple regions.

Sodium Hydrogen Carbonate is used in several clinical situations that require systemic alkalinization or gastric acid neutralization. - Metabolic acidosis: restores normal blood pH by providing bicarbonate ions. - Hyperkalemia: promotes intracellular shift of potassium, helping to lower serum potassium levels. - Gastric acid excess: neutralizes stomach acid to relieve heartburn and dyspepsia. - Urinary alkalinization: increases urine pH to prevent precipitation of certain kidney stones and to enhance excretion of specific drugs.

Sodium Hydrogen Carbonate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional episodes. - Abdominal discomfort: bloating or cramping. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe metabolic alkalosis: excessive rise in blood pH requiring medical intervention. - Hypernatremia: elevated serum sodium leading to neurological symptoms. - Anaphylactic reaction: rare allergic response with rash, swelling, and breathing difficulty.

When prescribing Sodium Hydrogen Carbonate, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: monitor serum electrolytes and acid‑base status. - Cardiac disease: caution due to added sodium load which may affect fluid balance. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment. - Concurrent acid‑lowering agents: assess for reduced efficacy or electrolyte disturbances. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium Hydrogen Carbonate can alter the pharmacokinetics or pharmacodynamics of various medicines.

Major Interactions (Avoid): - Lithium therapy: increased lithium reabsorption may cause toxicity. - Cytotoxic agents requiring acidic urine (e.g., methotrexate): alkalinization can reduce drug efficacy.

Moderate Interactions (Monitor Closely): - Aspirin and other NSAIDs: may diminish antacid protective effect. - Antibiotics such as tetracyclines or fluoroquinolones: reduced absorption when taken with alkalinizing agents. - Diuretics: heightened risk of electrolyte imbalances, especially hypokalemia.